(+)-pilocarpine decreases expression ISO RGD:1319319 6480464 Pilocarpine results in decreased expression of NFAT5 mRNA CTD PMID:21219332 (-)-demecolcine increases expression ISO RGD:1319318 6480464 Demecolcine results in increased expression of NFAT5 mRNA CTD PMID:23649840 1,2-dichloroethane decreases expression ISO RGD:1319319 6480464 ethylene dichloride results in decreased expression of NFAT5 mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:1319319 6480464 1, 2-Dimethylhydrazine results in decreased expression of NFAT5 mRNA CTD PMID:22206623 14-Deoxy-11,12-didehydroandrographolide increases expression ISO RGD:1319318 6480464 14-deoxy-11, 12-didehydroandrographolide results in increased expression of NFAT5 mRNA CTD PMID:22101062 17beta-estradiol decreases expression ISO RGD:1319318 6480464 Estradiol results in decreased expression of NFAT5 mRNA CTD PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1319319 6480464 Tetrachlorodibenzodioxin affects the expression of NFAT5 mRNA CTD PMID:18691609 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of NFAT5 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of NFAT5 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1319319 6480464 Tetrachlorodibenzodioxin results in increased expression of NFAT5 mRNA CTD PMID:21354282 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1319318 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of NFAT5 mRNA more ... CTD PMID:28628672 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1319319 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of NFAT5 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1319318 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of NFAT5 mRNA CTD PMID:28628672 4-hydroxyphenyl retinamide increases expression ISO RGD:1319319 6480464 Fenretinide results in increased expression of NFAT5 mRNA CTD PMID:28973697 5-azaorotic acid multiple interactions EXP 6480464 Allopurinol inhibits the reaction [Oxonic Acid affects the localization of NFAT5 protein] CTD PMID:30651350 5-azaorotic acid affects localization EXP 6480464 Oxonic Acid affects the localization of NFAT5 protein CTD PMID:30651350 7,9-dihydro-1H-purine-2,6,8(3H)-trione affects abundance ISO RGD:1319318 6480464 NFAT5 gene SNP affects the abundance of Uric Acid CTD PMID:23263486 7,9-dihydro-1H-purine-2,6,8(3H)-trione affects localization ISO RGD:1319318 6480464 Uric Acid affects the localization of NFAT5 protein CTD PMID:30651350 aflatoxin B1 increases expression ISO RGD:1319319 6480464 Aflatoxin B1 results in increased expression of NFAT5 mRNA CTD PMID:19770486 all-trans-retinoic acid increases expression ISO RGD:1319318 6480464 Tretinoin results in increased expression of NFAT5 mRNA CTD PMID:21934132 allopurinol multiple interactions ISO RGD:1319319 6480464 Allopurinol inhibits the reaction [Lipopolysaccharides promotes the reaction [NFAT5 protein binds to IL6 promoter]], Allopurinol inhibits the reaction [Lipopolysaccharides results in increased expression of NFAT5 mRNA] CTD PMID:23867654 allopurinol multiple interactions EXP 6480464 Allopurinol inhibits the reaction [Oxonic Acid affects the localization of NFAT5 protein] CTD PMID:30651350 apigenin multiple interactions ISO RGD:1319318 6480464 Apigenin inhibits the reaction [Sodium Chloride results in increased expression of NFAT5 mRNA] CTD PMID:26800359 Aroclor 1254 increases expression ISO RGD:1319318 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of NFAT5 mRNA CTD PMID:16934159 benzene increases expression ISO RGD:1319318 6480464 Benzene results in increased expression of NFAT5 mRNA CTD PMID:20359517 benzo[a]pyrene increases mutagenesis ISO RGD:1319318 6480464 Benzo(a)pyrene results in increased mutagenesis of NFAT5 gene CTD PMID:25435355 benzo[a]pyrene increases expression ISO RGD:1319319 6480464 Benzo(a)pyrene results in increased expression of NFAT5 mRNA CTD PMID:22228805 bisphenol A increases expression ISO RGD:1319319 6480464 bisphenol A results in increased expression of NFAT5 mRNA CTD PMID:26063408 bisphenol A multiple interactions ISO RGD:1319319 6480464 [bisphenol A co-treated with LIF protein] results in decreased expression of NFAT5 mRNA CTD PMID:30951980 bisphenol A multiple interactions ISO RGD:1319318 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of NFAT5 mRNA CTD PMID:28628672 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of NFAT5 mRNA CTD PMID:27571134 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of NFAT5 mRNA CTD PMID:25181051 bisphenol F multiple interactions ISO RGD:1319318 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NFAT5 mRNA CTD PMID:28628672 butanal decreases expression ISO RGD:1319318 6480464 butyraldehyde results in decreased expression of NFAT5 mRNA CTD PMID:26079696 cadmium dichloride decreases expression ISO RGD:1319319 6480464 Cadmium Chloride results in decreased expression of NFAT5 mRNA CTD PMID:24982889 cadmium dichloride increases expression ISO RGD:1319318 6480464 Cadmium Chloride results in increased expression of NFAT5 mRNA CTD PMID:26472689 carmustine affects response to substance ISO RGD:1319318 6480464 NFAT5 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 cerium trichloride increases expression ISO RGD:1319319 6480464 cerous chloride results in increased expression of NFAT5 mRNA CTD PMID:23573234 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of NFAT5 mRNA CTD PMID:18668222 cisplatin increases expression ISO RGD:1319319 6480464 Cisplatin results in increased expression of NFAT5 mRNA CTD PMID:21151649 copper atom multiple interactions ISO RGD:1319318 6480464 [NSC 689534 binds to Copper] which results in increased expression of NFAT5 mRNA CTD PMID:20971185 copper atom multiple interactions ISO RGD:1319319 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of NFAT5 mRNA CTD PMID:15467011 copper(0) multiple interactions ISO RGD:1319318 6480464 [NSC 689534 binds to Copper] which results in increased expression of NFAT5 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1319319 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of NFAT5 mRNA CTD PMID:15467011 copper(II) sulfate increases expression ISO RGD:1319318 6480464 Copper Sulfate results in increased expression of NFAT5 mRNA CTD PMID:19549813 crocidolite asbestos increases expression ISO RGD:1319318 6480464 Asbestos, Crocidolite results in increased expression of NFAT5 mRNA CTD PMID:18687144 crocidolite asbestos increases expression ISO RGD:1319319 6480464 Asbestos, Crocidolite results in increased expression of NFAT5 mRNA CTD PMID:19446018 cyclosporin A decreases expression ISO RGD:1319318 6480464 Cyclosporine results in decreased expression of NFAT5 mRNA CTD PMID:21632981 D-mannitol increases expression ISO RGD:1319319 6480464 Mannitol results in increased expression of NFAT5 mRNA CTD PMID:23867654 dexamethasone multiple interactions ISO RGD:1319318 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of NFAT5 mRNA more ... CTD PMID:28628672 dextran sulfate increases activity ISO RGD:1319319 6480464 Dextran Sulfate results in increased activity of NFAT5 protein CTD PMID:27920257 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of NFAT5 mRNA CTD PMID:21266533 dichloromethane increases expression ISO RGD:1319318 6480464 Methylene Chloride results in increased expression of NFAT5 mRNA CTD PMID:20359517 dorsomorphin multiple interactions ISO RGD:1319318 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin multiple interactions EXP 6480464 benzyloxycarbonyl-isoleucyl-glutamyl(O-tert-butyl)-alanyl-leucinal inhibits the reaction [Doxorubicin results in increased degradation of NFAT5 protein] more ... CTD PMID:17105721 doxorubicin decreases activity EXP 6480464 Doxorubicin results in decreased activity of NFAT5 protein CTD PMID:17105721 doxorubicin affects localization EXP 6480464 Doxorubicin affects the localization of NFAT5 protein CTD PMID:17105721 elemental selenium multiple interactions ISO RGD:1319318 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of NFAT5 mRNA CTD PMID:19244175 elemental selenium decreases expression ISO RGD:1319318 6480464 Selenium results in decreased expression of NFAT5 mRNA CTD PMID:19244175 endosulfan increases expression ISO RGD:1319318 6480464 Endosulfan results in increased expression of NFAT5 mRNA CTD PMID:26615145 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of NFAT5 mRNA CTD PMID:29391264 ethanol affects splicing ISO RGD:1319319 6480464 Ethanol affects the splicing of NFAT5 mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO RGD:1319318 6480464 Ethyl Methanesulfonate results in increased expression of NFAT5 mRNA CTD PMID:23649840 ethylbenzene increases expression ISO RGD:1319318 6480464 ethylbenzene results in increased expression of NFAT5 mRNA CTD PMID:20359517 formaldehyde increases expression ISO RGD:1319318 6480464 Formaldehyde results in increased expression of NFAT5 mRNA CTD PMID:16111024 , PMID:23649840 geldanamycin increases expression ISO RGD:1319318 6480464 geldanamycin results in increased expression of NFAT5 mRNA CTD PMID:26705709 genistein increases expression ISO RGD:1319318 6480464 Genistein results in increased expression of NFAT5 protein CTD PMID:20884965 genistein multiple interactions ISO RGD:1319318 6480464 ESR1 promotes the reaction [Genistein results in increased expression of NFAT5 protein] CTD PMID:20884965 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of NFAT5 mRNA CTD PMID:22061828 geraniol increases expression ISO RGD:1319318 6480464 geraniol results in increased expression of NFAT5 mRNA CTD PMID:27683099 indometacin multiple interactions ISO RGD:1319318 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of NFAT5 mRNA more ... CTD PMID:28628672 lipopolysaccharide increases expression ISO RGD:1319319 6480464 Lipopolysaccharides results in increased expression of NFAT5 mRNA CTD PMID:23867654 lipopolysaccharide decreases expression ISO RGD:1319319 6480464 Lipopolysaccharides results in decreased expression of NFAT5 mRNA CTD PMID:21219332 lipopolysaccharide affects localization ISO RGD:1319319 6480464 Lipopolysaccharides affects the localization of NFAT5 protein CTD PMID:23867654 lipopolysaccharide multiple interactions ISO RGD:1319319 6480464 Allopurinol inhibits the reaction [Lipopolysaccharides promotes the reaction [NFAT5 protein binds to IL6 promoter]] more ... CTD PMID:23867654 luteolin multiple interactions ISO RGD:1319318 6480464 Luteolin inhibits the reaction [Sodium Chloride results in increased expression of NFAT5 mRNA] CTD PMID:26800359 maleic acid increases expression ISO RGD:1319318 6480464 maleic acid results in increased expression of NFAT5 mRNA CTD PMID:28392987 maneb multiple interactions ISO RGD:1319319 6480464 [Paraquat co-treated with Maneb] affects the expression of NFAT5 mRNA CTD PMID:22563483 methamphetamine increases expression ISO RGD:1319319 6480464 Methamphetamine results in increased expression of NFAT5 mRNA CTD PMID:26307267 methotrexate increases expression ISO RGD:1319318 6480464 Methotrexate results in increased expression of NFAT5 mRNA CTD PMID:17400583 methyl methanesulfonate increases expression ISO RGD:1319318 6480464 Methyl Methanesulfonate results in increased expression of NFAT5 mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO RGD:1319318 6480464 methylmercuric chloride results in increased expression of NFAT5 mRNA CTD PMID:28001369 myxothiazol multiple interactions ISO RGD:1319318 6480464 myxothiazol inhibits the reaction [Sodium Chloride results in increased activity of NFAT5 protein] CTD PMID:16303854 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Doxorubicin results in increased degradation of NFAT5 protein] CTD PMID:17105721 nickel subsulfide decreases expression EXP 6480464 nickel subsulfide results in decreased expression of NFAT5 mRNA CTD PMID:24952340 o-xylene increases expression ISO RGD:1319318 6480464 2-xylene results in increased expression of NFAT5 mRNA CTD PMID:20359517 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of NFAT5 mRNA CTD PMID:25729387 ozone increases expression ISO RGD:1319318 6480464 Ozone results in increased expression of NFAT5 mRNA CTD PMID:27206323 paracetamol affects expression ISO RGD:1319319 6480464 Acetaminophen affects the expression of NFAT5 mRNA CTD PMID:17562736 paraquat increases expression ISO RGD:1319319 6480464 Paraquat results in increased expression of NFAT5 mRNA CTD PMID:22563483 paraquat multiple interactions ISO RGD:1319319 6480464 [Paraquat co-treated with Maneb] affects the expression of NFAT5 mRNA CTD PMID:22563483 phenobarbital affects expression ISO RGD:1319319 6480464 Phenobarbital affects the expression of NFAT5 mRNA CTD PMID:23091169 phenylmercury acetate increases expression ISO RGD:1319318 6480464 Phenylmercuric Acetate results in increased expression of NFAT5 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1319318 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFAT5 mRNA CTD PMID:27188386 pirinixic acid decreases expression ISO RGD:1319319 6480464 pirinixic acid results in decreased expression of NFAT5 mRNA CTD PMID:17950772 pirinixic acid multiple interactions ISO RGD:1319319 6480464 PPARA protein promotes the reaction [pirinixic acid results in decreased expression of NFAT5 mRNA] CTD PMID:17950772 progesterone decreases expression EXP 6480464 Progesterone results in decreased expression of NFAT5 mRNA CTD PMID:21371490 pyridaben increases expression ISO RGD:1319319 6480464 pyridaben results in increased expression of NFAT5 mRNA CTD PMID:22563483 quartz increases expression ISO RGD:1319318 6480464 Quartz results in increased expression of NFAT5 mRNA CTD PMID:27917503 quercetin multiple interactions ISO RGD:1319318 6480464 Quercetin inhibits the reaction [Sodium Chloride results in increased expression of NFAT5 mRNA] CTD PMID:26800359 quercetin increases expression ISO RGD:1319318 6480464 Quercetin results in increased expression of NFAT5 mRNA CTD PMID:21632981 reactive oxygen species multiple interactions ISO RGD:1319318 6480464 [Sodium Chloride results in increased abundance of Reactive Oxygen Species] which results in increased activity of NFAT5 protein CTD PMID:16303854 resveratrol decreases expression ISO RGD:1319318 6480464 resveratrol results in decreased expression of NFAT5 mRNA CTD PMID:25667456 rotenone multiple interactions ISO RGD:1319318 6480464 Rotenone inhibits the reaction [Sodium Chloride results in increased activity of NFAT5 protein] CTD PMID:16303854 rotenone multiple interactions ISO RGD:1319319 6480464 Rotenone inhibits the reaction [Sodium Chloride inhibits the reaction [Lipopolysaccharides promotes the reaction [NFAT5 protein binds to IL6 promoter]]] CTD PMID:23867654 SB 431542 multiple interactions ISO RGD:1319318 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 selenium atom multiple interactions ISO RGD:1319318 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of NFAT5 mRNA CTD PMID:19244175 selenium atom decreases expression ISO RGD:1319318 6480464 Selenium results in decreased expression of NFAT5 mRNA CTD PMID:19244175 sodium arsenate increases expression ISO RGD:1319319 6480464 sodium arsenate results in increased expression of NFAT5 mRNA CTD PMID:21795629 sodium chloride affects localization ISO RGD:1319319 6480464 Sodium Chloride affects the localization of NFAT5 protein CTD PMID:20823374 , PMID:23867654 sodium chloride increases expression ISO RGD:1319319 6480464 Sodium Chloride results in increased expression of NFAT5 mRNA, Sodium Chloride results in increased expression of NFAT5 protein CTD PMID:20823374 , PMID:23867654 sodium chloride multiple interactions ISO RGD:1319319 6480464 2-bromoethylamine inhibits the reaction [Sodium Chloride affects the localization of NFAT5 protein] more ... CTD PMID:20823374 , PMID:23867654 sodium chloride increases activity ISO RGD:1319318 6480464 Sodium Chloride results in increased activity of NFAT5 protein CTD PMID:16303854 sodium chloride multiple interactions ISO RGD:1319318 6480464 [Sodium Chloride results in increased abundance of Reactive Oxygen Species] which results in increased activity of NFAT5 protein more ... CTD PMID:16303854 , PMID:26800359 sodium chloride increases expression ISO RGD:1319318 6480464 Sodium Chloride results in increased expression of NFAT5 mRNA CTD PMID:26800359 succimer multiple interactions ISO RGD:1319319 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NFAT5 mRNA CTD PMID:21641980 sunitinib increases expression ISO RGD:1319318 6480464 Sunitinib results in increased expression of NFAT5 mRNA CTD PMID:31533062 temozolomide affects response to substance ISO RGD:1319318 6480464 NFAT5 mRNA affects the susceptibility to temozolomide CTD PMID:16365179 testosterone enanthate increases expression ISO RGD:1319318 6480464 testosterone enanthate results in increased expression of NFAT5 mRNA CTD PMID:17440010 thimerosal decreases expression ISO RGD:1319318 6480464 Thimerosal results in decreased expression of NFAT5 mRNA CTD PMID:27188386 toluene increases expression ISO RGD:1319318 6480464 Toluene results in increased expression of NFAT5 mRNA CTD PMID:20359517 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of NFAT5 mRNA CTD PMID:25729387 trichloroethene increases expression ISO RGD:1319318 6480464 Trichloroethylene results in increased expression of NFAT5 mRNA CTD PMID:20359517 trichostatin A increases expression ISO RGD:1319318 6480464 trichostatin A results in increased expression of NFAT5 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1319318 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFAT5 mRNA CTD PMID:27188386 troglitazone decreases expression ISO RGD:1319319 6480464 troglitazone results in decreased expression of NFAT5 mRNA CTD PMID:28973697 tungsten decreases expression ISO RGD:1319319 6480464 Tungsten results in decreased expression of NFAT5 mRNA CTD PMID:30912803 urethane increases expression ISO RGD:1319318 6480464 Urethane results in increased expression of NFAT5 mRNA CTD PMID:28818685 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of NFAT5 mRNA CTD PMID:29427782 valproic acid decreases methylation ISO RGD:1319318 6480464 Valproic Acid results in decreased methylation of NFAT5 gene CTD PMID:29501571 valproic acid decreases expression ISO RGD:1319318 6480464 Valproic Acid results in decreased expression of NFAT5 mRNA CTD PMID:29501571 vincristine increases expression ISO RGD:1319318 6480464 Vincristine results in increased expression of NFAT5 mRNA CTD PMID:23649840 vitamin E multiple interactions ISO RGD:1319318 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of NFAT5 mRNA CTD PMID:19244175 vitamin E decreases expression ISO RGD:1319318 6480464 Vitamin E results in decreased expression of NFAT5 mRNA CTD PMID:19244175 vorinostat decreases expression ISO RGD:1319318 6480464 vorinostat results in decreased expression of NFAT5 mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:1319318 6480464 vorinostat results in increased expression of NFAT5 mRNA CTD PMID:26272509 
Gene Ontology Annotations
